Skip to content

Product development based on Ora-pro-nobis and its influence on feces, blood tests and anthropometric data in Adult Men

Product development based on Ora-pro-nobis (Pereskia aculeata Mill.) and its influence on the intestinal microbiota, antioxidant capacity, anti-inflammatory, biochemical and anthropometric parameters in Adult Men

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4nj799
Enrollment
Unknown
Registered
2018-07-13
Start date
2017-06-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

05 men (Group 1) were overweight or obese at first receiving a biscuit containing 10 g / day of ora-pro-nobis meal. E 04 men (Group 2) received another biscuit, containing all the ingredients of the f
Other

Sponsors

Universidade Federal de Alfenas
Lead Sponsor
Universidade Federal de Alfenas
Collaborator

Eligibility

Sex/Gender
Male
Age
No minimum to 59 Years

Inclusion criteria

Inclusion criteria: Men between the ages of 20 and 50; Body mass index greater than or equal to 25 kg / m² and less than 40 kg / m²; Not having participated in a weight loss program in the last six months; Be healthy

Exclusion criteria

Exclusion criteria: History of alcohol or drug abuse; diagnoses of cardiac, renal, gastrointestinal, hepatic, pulmonary, neurological, psychiatric, hematological or metabolic pathologies; restrictive diet practices

Design outcomes

Primary

MeasureTime frame
Expected outcome 1: Reduction of gastrointestinal symptoms, assessed using the symptom rating scale questionnaire of at least 5 points of the total score, made 1 week pre and post intervention.;Expected outcome 2: Reduction of total cholesterol and fractions, assessed by laboratory tests performed 1 week pre and post intervention.;Expected outcome 3: Reduced fasting blood glucose, assessed by laboratory tests performed 1 week pre and post intervention.

Secondary

MeasureTime frame
Outcome found 1: There was reduction of gastrointestinal symptoms of at least 5 points of the total score, assessed by the symptom rating scale questionnaire made 1 week pre and post intervention.;Outcome Found 2:There was no reduction in total cholesterol and fractions, assessed by laboratory tests performed 1 week pre and post intervention.;Outcome Found 3: There was no reduction in fasting blood glucose, assessed by laboratory tests performed 1 week pre and post intervention.

Countries

Brazil

Contacts

Public ContactRoberta Silva

Universidade Federal de Alfenas

betaribeiro@hotmail.com+55-35-32991106

Outcome results

None listed

Source: REBEC (via WHO ICTRP)